Page last updated: 2024-10-18

dihydroxyphenylalanine and DiGeorge Syndrome

dihydroxyphenylalanine has been researched along with DiGeorge Syndrome in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

DiGeorge Syndrome: Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rogdaki, M1
Devroye, C1
Ciampoli, M1
Veronese, M1
Ashok, AH1
McCutcheon, RA1
Jauhar, S1
Bonoldi, I1
Gudbrandsen, M1
Daly, E1
van Amelsvoort, T1
Van Den Bree, M1
Owen, MJ1
Turkheimer, F1
Papaleo, F1
Howes, OD1

Other Studies

1 other study available for dihydroxyphenylalanine and DiGeorge Syndrome

ArticleYear
Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
    Molecular psychiatry, 2023, Volume: 28, Issue:5

    Topics: DiGeorge Syndrome; Dihydroxyphenylalanine; DNA Copy Number Variations; Dopamine; Humans; Positron-Em

2023